<DOC>
	<DOCNO>NCT00019643</DOCNO>
	<brief_summary>RATIONALE : Chemotherapy may affect various factor lead weight gain . PURPOSE : Clinical trial evaluate factor may affect weight gain woman receive adjuvant chemotherapy stage I , stage II , stage IIIA breast cancer .</brief_summary>
	<brief_title>Factors Affecting Weight Gain Women Receiving Adjuvant Chemotherapy Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Evaluate relative contribution factor may lead weight gain breast cancer patient receive adjuvant chemotherapy . Factors examine include : Hormonal growth factor status ( follicle stimulate hormone , total , bound , free estradiol , androgen , sex hormone bind globulin , thyroid hormone , prolactin , insulin-like growth factor I II , plasma leptin ) Factors affect energy intake expenditure ( oral intake , physical activity , rest metabolic rate ) Psychological factor ( depression quality life ) II . Evaluate effect chemotherapy hormonal growth factor status patient . III . Assess impact chemotherapy bone marrow density patient . PROTOCOL OUTLINE : Data collect woman diagnose primary breast cancer 3 point ( 5 visit ) : ( ) breast cancer surgery , chemotherapy begin ( 2 visit NIH day hospital 1 week apart ) ; ( ii ) 2-3 week chemotherapy end ( 2 visit , 1 week apart ) ; ( iii ) 6 month chemotherapy end ( 1 visit ) . Tests conduct visit include evaluation blood hormone , growth factor , leptin ; body composition DXA ; visceral subcutaneous abdominal adipose tissue axial CT scan ; evaluation rest metabolic rate daily energy expenditure single administration doubly label water visit `` '' `` b '' data collection timepoints 1 2 . Questionnaires assess epidemiologic risk factor breast cancer , dietary intake , physical activity , depression , quality life also administer three timepoints . PROJECTED ACCRUAL : A total 140 patient accrue study within 1-2 year .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Depression</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Histologically prove newly diagnose stage I , II , resectable IIIA primary breast cancer Scheduled receive chemotherapy No distant metastases Prior/Concurrent Therapy Biologic therapy : Not specify Chemotherapy : See Disease Characteristics No concurrent neoadjuvant chemotherapy Endocrine therapy : No concurrent thyroid medication Radiotherapy : No concurrent radiotherapy Surgery : See Disease Characteristics No prior oophorectomy Other : No concurrent alternative medicine alone No concurrent participation dietary and/or exercise weight loss program Patient Characteristics Age : 18 80 Sex : Female Menopausal status : Premenopausal postmenopausal Performance status : Not specify Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : No physical mental disability would preclude complete questionnaire No prior concurrent diabetes mellitus No prior hypothyroidism hyperthyroidism</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>adult solid tumor</keyword>
	<keyword>body system/site cancer</keyword>
	<keyword>breast cancer</keyword>
	<keyword>cancer</keyword>
	<keyword>cancer-related problem/condition</keyword>
	<keyword>depression</keyword>
	<keyword>depression suicide</keyword>
	<keyword>nutrition</keyword>
	<keyword>psychosocial effects/treatment</keyword>
	<keyword>quality life</keyword>
	<keyword>solid tumor</keyword>
	<keyword>stage I breast cancer</keyword>
	<keyword>stage I , II , IIIA breast cancer</keyword>
	<keyword>stage II breast cancer</keyword>
	<keyword>stage III breast cancer</keyword>
	<keyword>stage IIIA breast cancer</keyword>
	<keyword>stage IIIB , IV , recurrent , metastatic breast cancer</keyword>
	<keyword>stage , breast cancer</keyword>
</DOC>